Argent Biopharma LtdASX: RGT

Notification of cessation of securities - RGT

Aug 3, 2026 at 3:16 AM EDT · Issued by Argent Biopharma Ltd via ASX

Filed with ASX · Aug 3, 2026 at 3:16 AM EDT · 5 pages · English

On 6ix: 6ix.com/news/notification-of-cessation-of-securities-rgt-1

Release

Appendix 3H - Notification of cessation of securities Appendix 3H - Notification of cessation of securities 1 / 5 Announcement Summary Entity name ARGENT BIOPHARMA LIMITED Announcement Type New announcement Date of this announcement Monday August 03, 2026 Details of +securities that have...

Argent Biopharma Ltd on 6ix

Earlier from Argent Biopharma

CannEpil Global Licence Expands into Veterinary HealthcareJul 30
Quarterly Activities/Appendix 4C Cash Flow ReportJul 27
RGT Executes Global CannEpil Licensing Deal for US$5.5MJul 6
Half Yearly Report and AccountsFeb 27
Provisional Patent Lodged with USPTO for NanoBodies PlatformFeb 24

Later from Argent Biopharma

US Veterinary Development Programme for CannEpil CommencesAug 5
$250,000 in Funding Received under Financing FacilityAug 10
Proposed issue of securities - RGTAug 10
FDA-CVM Establish INAD File for CannEpil Veterinary ProgramAug 25
Appendix 4G and Corporate Governance StatementAug 31

All Argent Biopharma news releases

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma